Author:
Watt Lauren F.,Panicker Nikita,Mannan Abdul,Copeland Ben,Kahl Richard G. S.,Dun Matthew D.,Young Barbara,Roselli Severine,Verrills Nicole M.
Funder
Cure Cancer Australia Foundation
Cancer Council NSW
Pink Frangipani Ball
Cancer Institute NSW
Hunter Medical Research Institute
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Kenemans P, Verstraeten RA, Verheijen RH (2004) Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas 49(1):34–43
2. Singletary SE (2002) A working model for the time sequence of genetic changes in breast tumorigenesis. J Am Coll Surg 194(2):202–216
3. Karakosta A, Golias C, Charalabopoulos A, Peschos D, Batistatou A, Charalabopoulos K (2005) Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. J Exp Clin Cancer Res. 24(4):505–514
4. Adams DG, Coffee RL Jr, Zhang H, Pelech S, Strack S, Wadzinski BE (2005) Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J Biol Chem 280(52):42644–42654
5. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW (2008) Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283(4):1882–1892
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献